J&J starts clinical trial of Ebola vaccine in Sierra Leone

by Reuters
Friday, 9 October 2015 06:14 GMT

Oct 9 (Reuters) - Johnson & Johnson said it has begun a safety and immunogenicity clinical trial of a preventive Ebola vaccine regimen in Sierra Leone.

Trial recruitment is underway and the first volunteers have received their initial vaccine dose, the company said in a statement.

This is the first study conducted of Janssen's Ebola prime-boost vaccine regimen in a West African country affected by the recent Ebola epidemic, J&J said. (Reporting by Supriya Kurane in Bengaluru; Editing by Anupama Dwivedi)

Our Standards: The Thomson Reuters Trust Principles.